The fully linked HTML version of this article has now been published.
Development ePress online publication date 2 Feb 2005
doi: 10.1242/dev.01640
Research article: Development and disease
Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart
Bin Zhou*,
Bingruo Wu,
Kevin L. Tompkins,
Kathleen L. Boyer,
Justin C. Grindley,
and
H. Scott Baldwin
* Author for correspondence (e-mail: bin.zhou{at}vanderbilt.edu)
Nfatc1 is an endocardial transcription factor required for development of cardiac valves. Herein, we describe identification and characterization of a tissue-specific enhancer in the first intron of murine Nfatc1 that activates a heterogenic promoter and directs gene expression in a subpopulation of endocardial cells of the developing heart: the pro-valve endocardial cells. This enhancer activity begins on embryonic day (E) 8.5 in endocardial cells at the ventricular end of the atrioventricular canal, intensifies and extends from E9.5 to E11.5 in endocardium along the atrioventricular canal and outflow tract. By E12.5, the enhancer activity is accentuated in endocardial cells of forming valves. Sequential deletion analysis identified that a 250 bp DNA fragment at the 3' end of the intron 1 is required for endocardial-specific activity. This region contains two short conserved sequences hosting a cluster of binding sites for transcription factors, including Nfat and Hox proteins. Electrophoresis mobility shift and chromatin immunoprecipitation assays demonstrated binding of Nfatc1 to the Nfat sites, and inactivation of Nfatc1 downregulated the enhancer activity in pro-valve endocardial cells. By contrast, mutation of the Hox site abolished its specificity, allowing gene expression in non pro-valve endocardium and extracardiac vasculature. Thus, autoregulation of Nfatc1 is required for maintaining high Nfatc1 expression in pro-valve endocardial cells, while suppression through the Hox site prevents its expression outside pro-valve endocardial cells during valve development. Our data demonstrate the first autonomous cell-specific enhancer for pro-valve endocardial cells and delineate a unique transcriptional mechanism that regulates endocardial Nfatc1 expression within developing cardiac valves.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
T. R. Torgerson, A. Genin, C. Chen, M. Zhang, B. Zhou, S. Anover-Sombke, M. B. Frank, I. Dozmorov, E. Ocheltree, P. Kulmala, et al.
FOXP3 Inhibits Activation-Induced NFAT2 Expression in T Cells Thereby Limiting Effector Cytokine Expression
J. Immunol.,
July 15, 2009;
183(2):
907 - 915.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Langworthy, B. Zhou, M. de Caestecker, G. Moeckel, and H. S. Baldwin
NFATc1 Identifies a Population of Proximal Tubule Cell Progenitors
J. Am. Soc. Nephrol.,
February 1, 2009;
20(2):
311 - 321.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Snider, R. B. Hinton, R. A. Moreno-Rodriguez, J. Wang, R. Rogers, A. Lindsley, F. Li, D. A. Ingram, D. Menick, L. Field, et al.
Periostin Is Required for Maturation and Extracellular Matrix Stabilization of Noncardiomyocyte Lineages of the Heart
Circ. Res.,
April 11, 2008;
102(7):
752 - 760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Wu, S.-c. Kao, T. Barrientos, S. H. Baldwin, E. N. Olson, G. R. Crabtree, B. Zhou, and C.-P. Chang
Down Syndrome Critical Region-1 Is a Transcriptional Target of Nuclear Factor of Activated T Cells-c1 within the Endocardium during Heart Development
J. Biol. Chem.,
October 19, 2007;
282(42):
30673 - 30679.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Song, W. Yan, X. Chen, C.-x. Deng, Q. Wang, and K. Jiao
Myocardial Smad4 Is Essential for Cardiogenesis in Mouse Embryos
Circ. Res.,
August 3, 2007;
101(3):
277 - 285.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Khandekar, W. Brandt, Y. Zhou, S. Dagenais, T. W. Glover, N. Suzuki, R. Shimizu, M. Yamamoto, K.-C. Lim, and J. D. Engel
A Gata2 intronic enhancer confers its pan-endothelia-specific regulation
Development,
May 1, 2007;
134(9):
1703 - 1712.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Zubair, S. Ishihara, S. Oka, K. Okumura, and K.-i. Morohashi
Two-Step Regulation of Ad4BP/SF-1 Gene Transcription during Fetal Adrenal Development: Initiation by a Hox-Pbx1-Prep1 Complex and Maintenance via Autoregulation by Ad4BP/SF-1.
Mol. Cell. Biol.,
June 1, 2006;
26(11):
4111 - 4121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Beis, T. Bartman, S.-W. Jin, I. C. Scott, L. A. D'Amico, E. A. Ober, H. Verkade, J. Frantsve, H. A. Field, A. Wehman, et al.
Genetic and cellular analyses of zebrafish atrioventricular cushion and valve development
Development,
September 15, 2005;
132(18):
4193 - 4204.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2005
